Skip to main content
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
517.20
+9.15 (1.80%)
Mar 12, 2025, 9:15 AM IST

NSE:AKUMS Revenue

Akums Drugs and Pharmaceuticals had revenue of 10.10B INR in the quarter ending December 31, 2024, a decrease of -6.69%. This brings the company's revenue in the last twelve months to 40.10B, down -3.40% year-over-year. In the fiscal year ending March 31, 2024, Akums Drugs and Pharmaceuticals had annual revenue of 41.82B with 14.34% growth.

Revenue (ttm)
40.10B
Revenue Growth
-3.40%
P/S Ratio
1.87
Revenue / Employee
5.43M
Employees
7,388
Market Cap
79.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 202127.26B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Akums Drugs and Pharmaceuticals News

More News